Antibiotic susceptibilities of recent isolates of  Mycopasma bovis  in Belgium | Zendy

Thomas A. | Zendy; Nicolas C. | Zendy; Dizier I. | Zendy; Mainil J. | Zendy; Linden A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Antibiotic susceptibilities of recent isolates of Mycopasma bovis in Belgium

Author(s) -

Thomas A.,

Nicolas C.,

Dizier I.,

Mainil J.,

Linden A.

Publication year - 2003

Publication title -

veterinary record

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.261

H-Index - 99

eISSN - 2042-7670

pISSN - 0042-4900

DOI - 10.1136/vr.153.14.428

Subject(s) - antibiotics , microbiology and biotechnology , biology , veterinary medicine , medicine

The susceptibilities of 40 recent Belgian field isolates of Mycoplasma bovis to 10 antimicrobial agents were assessed. Tiamulin was the most active antimicrobial agent against M bovis , with an initial inhibitory concentration (IIC50) of 0‐06 μg/ml, but it is not licensed for the treatment of cattle. All three fluoroquinolones tested (danofloxacin, enrofloxacin and marbofloxacin) were effective against strains of M bovis , and had a minimum mycoplasmacidal concentration (MMC50) less than or equal to 1 μg/mI. Gentamicin was poorly effective, having an IIC50 of 8 μg/mI. Many strains of M bovis were resistant to tylosin, spectinomycin, lincomycin, tetracycline and oxytetracycline.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research